Art

J-GLOBAL ID：201802264064772342   Reference number：18A1391022

Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer

ゾレドロン酸により誘導される急性相反応と進行性非小細胞肺癌患者の予後に及ぼすその影響【JST・京大機械翻訳】

Author (14)： Izumi Hiroki (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Yamasaki Akira (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Takeda Kenichi (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Kodani Masahiro (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Touge Hirokazu (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Tanaka Natsumi (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Yanai Masaaki (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Ueda Yasuto (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Sakamoto Tomohiro (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Nishii-Ito Shizuka (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Makino Haruhiko (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Yamaguchi Kosuke (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Igishi Tadashi (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan) ,  Shimizu Eiji (Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, 36-1, Nishi-machi, Yonago, 683-8504, Japan)
Material： Lung Cancer
Volume： 122  Page： 200-205  Publication year： 2018 
JST Material Number： W3184A  ISSN： 0169-5002  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Zoledronate (ZOL) is usually u...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1391022&from=J-GLOBAL&jstjournalNo=W3184A") }}

Thesaurus term： TNF ,  *non-small cell lung cancer ,  Serum ,  EGF receptor ,  *patient ,  cytokine ,  interleukin 6 ,  administration (biology) ,  gamma delta T cell ,  *cancer patient ,  Bone metastases ,  Advanced non-small cell lung cancer
Semi thesaurus term： 生存期間中央値 ,  後向き研究 ,  急性期反応 , 【Automatic Indexing@JST】

Author keywords (5)： Non-small cell lung cancer ,  Zoledronate ,  Acute-phase reaction ,  γδ T cell ,  Epidermal growth factor receptor

JST classification (2)： Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Terms in the title (5)： ゾレドロン酸 ,  誘導 ,  急性相反応 ,  進行性非小細胞肺癌 ,  患者の予後